Skip to Main Content
The first stop for professional medicines advice

Progestogen-Only Intra-Uterine Device (LNG-IUD) for contraception

Published Last updated See all updates
Topics: LevonorgestrelPatient Group DirectionsReproductive healthTemplates

SPS PGD template for the insertion of the Progestogen-Only Intra-Uterine Device (LNG-IUD) for contraception.

Contents

  1. Provenance
  2. Planned Review
  3. PGD template attachment
  4. Patient Group Directions, Templates, Reproductive health
  5. All PGD templates
  6. Update history

Provenance

Written by SPS and the College of Sexual and Reproductive Health (CoSRH), with the support of specialist stakeholders working within clinical practice, for use within reproductive services.

August 2025 – note the Faculty of Sexual and Reproductive Healthcare (FSRH) has now changed its name to the College of Sexual and Reproductive Healthcare (CoSRH). Some web pages and CoSRH documents will continue to display the FSRH name; where you see FSRH, this refers to CoSRH. All weblinks are still active.

Planned Review

Following the December 2025 launch of revised UKMEC guidelines from CoSRH, all reproductive health PGD/protocols are being reviewed to ensure they reflect the updated UKMEC.

There are minor changes that apply to this PGD template, which will be covered in the planned end of life review in late spring.

  • References to intrauterine contraception (IUC) or intrauterine systems (IUS) have been replaced with intrauterine device (IUD) to reflect WHO terminology.
  • Living with HIV – removal of all reference to CD4 counts, and using person-centred language so will state “living with HIV infection if clinically unwell and not on treatment”.
  • Amendment to exclusion regarding IHD. Stroke and TIA are now UKMEC 2 so have been removed.

PGD template attachment

The template PGD is attached below to download and use in conjunction with our implementation advice (SPS page).

Patient Group Directions, Templates, Reproductive health

All PGD templates

National PGD, protocol and written instructions templates

National templates are developed with experts for clinical specialties. They reduce duplication and variation, and improve consistency of care.

Update history

  1. Republished
  2. Planned review detail added
  1. Information added regarding name change of FSRH to CoSRH
  1. Updated PGD template published. Statement added to off-label use section regarding extended use of 8 years for all 52mg products in line with FSRH statement. Uterine perforation added as exclusion.
  1. Updated added regarding FSRH 9th May published recommendation update
  1. Updated template published
  1. Detail regarding pending update added.
  1. Version 2.1 published - minor amendment
  1. V1 removed from website as expiring 31/7/23
  1. Title, URL and summary amended.
  1. New V2.0 template added
  1. Updated template attached - new product added
  1. Template republished with minor rewording
  1. Published